Halozyme Therapeutics
HALO
#2440
Rank
ยฃ4.69 B
Marketcap
ยฃ36.91
Share price
-13.62%
Change (1 day)
14.45%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: ยฃ4.69 Billion

As of November 2024 Halozyme Therapeutics has a market cap of ยฃ4.69 Billion. This makes Halozyme Therapeutics the world's 2440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ4.69 B22.52%
2023ยฃ3.83 B-39.74%
2022ยฃ6.35 B51.64%
2021ยฃ4.19 B-0.99%
2020ยฃ4.23 B129.15%
2019ยฃ1.84 B10.82%
2018ยฃ1.66 B-21.84%
2017ยฃ2.13 B105.82%
2016ยฃ1.03 B-30.81%
2015ยฃ1.49 B92.32%
2014ยฃ0.77 B-25.13%
2013ยฃ1.04 B122.44%
2012ยฃ0.46 B-26.25%
2011ยฃ0.63 B22.95%
2010ยฃ0.51 B55.16%
2009ยฃ0.33 B6.87%
2008ยฃ0.31 B11.61%
2007ยฃ0.27 B-1.3%
2006ยฃ0.28 B344.27%
2005ยฃ63.58 M12.77%
2004ยฃ56.38 M

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of Halozyme Therapeutics was reported to be:

ยฃ5.43 Billion
by Nasdaq info icon info icon
ยฃ5.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ1.46 B-68.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ563.93 B 11,910.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.95 B 175.96%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ111.58 B 2,276.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ99.77 B 2,025.03%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ293.92 B 6,159.76%๐Ÿ‡บ๐Ÿ‡ธ USA